期刊文献+

地塞米松对小鼠DC2.4细胞表型及功能的影响 被引量:1

Effects of dexamethasone on the phenotype and function of mouse DC2.4 cell line
在线阅读 下载PDF
导出
摘要 目的研究地塞米松(dexamethasone,Dex)对DC2.4细胞表型及功能的影响。方法取生长状态良好的DC2.4细胞,随机分为4组,A组为对照组;B、C、D组分别为50、100、200μg/L地塞米松组,每组DC2.4细胞培养6d。用流式细胞术测定DC表面CD80,CD86,Galectin-9及PD-L1的表达,ELISA方法检测其培养上清IL-12的浓度,用混合淋巴细胞培养法检测其对同种异体T细胞的刺激能力。结果与对照组相比,经不同剂量地塞米松修饰的DC2.4细胞其表面CD80,CD86,Galectin-9及PD-L1的表达无明显改变,但地塞米松用药组显著减少IL-12的分泌及抑制刺激同种异体T细胞增殖的能力。结论 DC2.4细胞是一细胞表型稳定的细胞系;地塞米松没有明显改变其细胞表型,但抑制其细胞因子的分泌,降低其刺激同种异体反应T细胞增殖的能力。 We aim to study the effect of dexamethasone (Dex) on phenotype and function of mouse DC2.4 cell line. DC2.4 cells which grew well were divided into 4 groups:control,50 μg/L,100 μg/L,and 200 μg/L Dex groups. And DC2.4 cells in every group were cultured for 6 days. Flow cytometry indicated there was no significant difference of CD80,CD86,Galectin-9,and PD-L1 expressions between control group and DC2.4 cells treated with different doses of Dex. However,ELISA and mixed lymphocyte reaction showed that Dex treatment reduced IL-12 level secreted by DC and inhibited the stimulating activity of DC2.4 cells on allogeneic T cells significantly. We concluded that the DC2.4 is a phenotype stable cell line; Dex does not significantly change the cell phenotype,but inhibits the secretion of cytokines,reduces the stimulation of allogeneic T cell proliferation response capacity.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第9期759-763,共5页 Immunological Journal
基金 国家自然科学基金项目(30973245)
关键词 DC2.4 半乳糖凝集素-9 程序化死亡因子配体1 地塞米松 免疫耐受 DC2.4 Galectin-9 PD-L1 Dexamethasone Immune tolerance
  • 相关文献

参考文献3

二级参考文献33

  • 1吴奎,孙鲲,毕玉田,夏俊波,王长征.哮喘小鼠CD4^+CD25^+调节性T细胞数量及功能的改变[J].中国呼吸与危重监护杂志,2005,4(6):455-458. 被引量:16
  • 2孙鲲,林科雄,吴奎,王长征.CD_4^+ CD_(25)^+T淋巴细胞对支气管哮喘小鼠气道炎症的影响及作用机制[J].中华结核和呼吸杂志,2006,29(2):109-112. 被引量:15
  • 3宋云熙,曾雪峰,夏俊波,王长征.大剂量过敏原诱导哮喘小鼠T细胞不反应性及机制研究[J].免疫学杂志,2007,23(3):274-276. 被引量:7
  • 4Rosignoli G, Lim CH, Bower M, et al. Programmed death (PD)- 1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1- infected individuals[J]. Clin Exp Immunol, 2009,157 ( 1 ) :90- 97.
  • 5WaismanA, Yogev N. B7-H1 and CD8 ^+ Treg: the enigmatic role of B7-H1 in peripheral tolerance [ J]. Eur J Imnmnol, 2009, 39 (6) : 1448-1451.
  • 6Rilev JL. PD-1 signaling in primary T cells [J]. Immunol Rev, 2009, 229(1) : 114-125.
  • 7Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production [J]. J Immunol, 2005, 175 (3) : 1257- 1266.
  • 8Zhang L, Gajewski TF, Kline J, et al. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leu- kemia model [J]. Blood, 2009, 114(8) : 1545-1552.
  • 9Parekh VV, Lalani S, Kim S, et al. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells [ J]. J Immunol, 2009, 182(5) : 2816-2826.
  • 10Wu YF, Wan T, Zhou XY, et al. HSP70-1ike protein 1 fusion protein enhance induction of carcinoembryonic antigen-specific CD8 ^+ CTL response by dentritic cell vaccine [J]. Cancer Res, 2005, 65( 11 ) : 4947-4954.

共引文献11

同被引文献14

  • 1Tong J, Liu C, Summanen P, et al. Corynebacterium pyruviciproducens sp. nov., a pyruvie acid producer [J]. Int J Syst Evol Mierobiol, 2010, 60 (5): 1135-1140.
  • 2Warr GW, James K. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes [J]. Im- munology, 1975, 28 (3): 431-442.
  • 3Mnssalem JS, Vasconcelos JRC, Squaiella CC, et al. Adju- vant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene[J]. Microbiol Im- munol, 2006, 50 (4): 253-263.
  • 4Nussenzweig R. Increased nonspecific resistance to malaria produced by administration of killed Corynebacterium parvum[J]. Exp Parasitol, 1967, 21 (2): 224-231.
  • 5Li BQ, Dong X, Fang SH, et al. Systemic toxicity of non-cell corynebacterium parvum (CP) in monkeys [J]. J Toxicol Sci, 2010, 35 (3): 279-286.
  • 6Gao S, Liu C, Qu S, et al. Non-cell Corynebacterium parvum generated by nanotechnology: a promising immunomodulator with less side effects[J]. Int Immunopharmacol, 2007, 7 (10): 1334-1342.
  • 7Langhome J, Albano FR, Hensmann M, et al. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection[J]. Immunol Rev, 2004, 201 (1): 35-47.
  • 8Park SJ, Nakagawa T, Kitamura H, et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation [J]. J Immunol, 2004, 173 (6): 3844-3854.
  • 9Frick JS, Grunebach F, Autenrieth IB. Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6 [J]. Int J Med Microbiol, 2010, 300 (1): 19-24.
  • 10Kimura A, Kistlimoto T. IL-6: Regulator of Treg/Thl7 bal- ance[J]. Eur J hnmunol, 2010, 40 (7): 1830-1835.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部